Ustekinumab 45MG/0.5ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FX00J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,234
Award facts
- Contract value 100% obligated
- $5,233.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $5,233.70 delivery order to Amerisourcebergen Drug Corp on July 14, 2026, for Ustekinumab 45mg/0.5ml syringes under firm fixed-price terms, with ultimate completion by August 4, 2026.
Place of performance is Conshohocken, PA. The order is issued under the DLA Troop Support Medical indefinite delivery contract vehicle supporting pharmaceutical supply to Defense Health Agency and military medical facilities globally.
Quick answers
Who was awarded contract SPE2DR26FX00J?
SPE2DR26FX00J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2026.
How much is contract SPE2DR26FX00J worth?
The government has obligated $5,234 on SPE2DR26FX00J.
Is contract SPE2DR26FX00J an order under another contract?
Yes. SPE2DR26FX00J is a delivery order under SPE2DR25D3011, an indefinite delivery contract.
Was contract SPE2DR26FX00J competed?
The extent of competition for SPE2DR26FX00J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award